Vasculogenic mimicry in vitro in tumour cells derived from metastatic malignant pleural effusions.

Francesca Sasanelli,A. Hocking,E. Pulford,Yazad D. Irani,S. Klebe

DOI: https://doi.org/10.1016/j.pathol.2017.03.010

2017-07-06

Abstract:

What problem does this paper attempt to address?

Positive Airway Pressure in Surgical Patients with Sleep Apnea: What is the Supporting Evidence?

Linor Berezin,Frances Chung

DOI: https://doi.org/10.1213/ane.0000000000006894

IF: 6.627

2024-02-12

Anesthesia & Analgesia

Abstract:Obstructive sleep apnea (OSA) is prevalent amongst surgical patients and associated with an increased incidence of perioperative complications. The gold standard treatment for moderate-to-severe OSA is positive airway pressure (PAP) therapy. Practice guidelines by the American Society of Anesthesiologists and the Society of Anesthesia and Sleep Medicine have recommended preoperative screening for OSA and consideration of initiation of PAP therapy for patients with severe OSA. These guidelines, developed mainly by the consensus of experts, highlight the adverse impact of OSA on postoperative outcomes and recommend the use of postoperative PAP in surgical patients with moderate to severe OSA. Since the development of these guidelines, there has been an increase in the number of publications regarding the efficacy of PAP therapy in surgical patients with OSA. Our review provides an update on the existing literature on the efficacy of PAP therapy in surgical patients with OSA. We focus on the postoperative complications associated with OSA, potential mechanisms leading to the increased risk of postoperative adverse events, and summarize the perioperative guidelines for the management of patients with OSA, evidence supporting perioperative PAP therapy, as well as limitations to PAP therapy and alternatives. An update on the existing literature of the efficacy of PAP therapy in surgical patients with OSA is critical to assess the impact of prior guidelines, determine when and how to effectively implement PAP therapy, and target barriers to PAP adherence in the perioperative setting.

anesthesiology
Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery

Claire J Ireland,Timothy M Chapman,Suneeth F Mathew,G Peter Herbison,Mathew Zacharias

DOI: https://doi.org/10.1002/14651858.cd008930.pub2

IF: 8.4

2014-08-01

Cochrane Database of Systematic Reviews

Abstract:BACKGROUND: Major abdominal surgery can be associated with a number of serious complications that may impair patient recovery. In particular, postoperative pulmonary complications (PPCs), including respiratory complications such as atelectasis and pneumonia, are a major contributor to postoperative morbidity and may even contribute to increased mortality. Continuous positive airway pressure (CPAP) is a type of therapy that uses a high-pressure gas source to deliver constant positive pressure to the airways throughout both inspiration and expiration. This approach is expected to prevent some pulmonary complications, thus reducing mortality.OBJECTIVES: To determine whether any difference can be found in the rate of mortality and adverse events following major abdominal surgery in patients treated postoperatively with CPAP versus standard care, which may include traditional oxygen delivery systems, physiotherapy and incentive spirometry.SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 9; Ovid MEDLINE (1966 to 15 September 2013); EMBASE (1988 to 15 September 2013); Web of Science (to September 2013) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (to September 2013).SELECTION CRITERIA: We included all randomized controlled trials (RCTs) in which CPAP was compared with standard care for prevention of postoperative mortality and adverse events following major abdominal surgery. We included all adults (adults as defined by individual studies) of both sexes. The intervention of CPAP was applied during the postoperative period. We excluded studies in which participants had received PEEP during surgery.DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies that met the selection criteria from all studies identified by the search strategy. Two review authors extracted the data and assessed risk of bias separately, using a data extraction form. Data entry into RevMan was performed by one review author and was checked by another for accuracy. We performed a limited meta-analysis and constructed a summary of findings table.MAIN RESULTS: We selected 10 studies for inclusion in the review from 5236 studies identified in the search. These 10 studies included a total of 709 participants. Risk of bias for the included studies was assessed as high in six studies and as unclear in four studies.Two RCTs reported all-cause mortality. Among 413 participants, there was no clear evidence of a difference in mortality between CPAP and control groups, and considerable heterogeneity between trials was noted (risk ratio (RR) 1.28, 95% confidence interval (CI) 0.35 to 4.66; I(2) = 75%).Six studies reported demonstrable atelectasis in the study population. A reduction in atelectasis was observed in the CPAP group, although heterogeneity between studies was substantial (RR 0.62, 95% CI 0.45 to 0.86; I(2) = 61%). Pneumonia was reported in five studies, including 563 participants; CPAP reduced the rate of pneumonia, and no important heterogeneity was noted (RR 0.43, 95% CI 0.21 to 0.84; I(2) = 0%). The number of participants identified as having serious hypoxia was reported in two studies, with no clear difference between CPAP and control groups, given imprecise results and substantial heterogeneity between trials (RR 0.48, 95% CI 0.22 to 1.02; I(2) = 67%). A reduced rate of reintubation was reported in the CPAP group compared with the control group in two studies, and no important heterogeneity was identified (RR 0.14, 95% CI 0.03 to 0.58; I(2) = 0%). Admission into the intensive care unit (ICU) for invasive ventilation and supportive care was reduced in the CPAP group, but this finding did not reach statistical significance (RR 0.45, 95% CI 0.18 to 1.14; I(2) = 0).Secondary outcomes such as length of hospital stay and adverse effects were only minimally reported.A summary of findings table was constructed using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) principle. The quality of evidence was determined to be very low.AUTHORS' CONCLUSIONS: Very low-quality evidence from this review suggests that CPAP initiated during the postoperative period might reduce postoperative atelectasis, pneumonia and reintubation, but its effects on mortality, hypoxia or invasive ventilation are uncertain. Evidence is not sufficiently strong to confirm the benefits or harms of CPAP during the postoperative period in those undergoing major abdominal surgery. Most of the included studies did not report on adverse effects attributed to CPAP.New, high-quality research is much needed to evaluate the use of CPAP in preventing mortality and morbidity following major abdominal surgery. With increasing availability of CPAP to our surgical patients and its potential to improve outcomes (possibly in conjunction with intraoperative lung protective ventilation strategies), unanswered questions regarding its efficacy and safety need to be addressed. Any future study must report on the adverse effects of CPAP.

medicine, general & internal
Reconsidering first-line treatment for obstructive sleep apnea: a systematic review of the literature

Brian W Rotenberg,Claudio Vicini,Edward B Pang,Kenny P Pang

DOI: https://doi.org/10.1186/s40463-016-0136-4

2016-04-06

Abstract:Background: Continuous positive airway pressure (CPAP) is typically recommended as first line therapy for obstructive sleep apnea, but the adherence rate of CPAP is problematic. This study's objective was to systematically review the literature relating to CPAP as first line therapy for OSA and compare it to surgical literature on the same topic. Methods: A systematic review was conducted according to PRISMA guidelines, examining Medline-Ovid, Embase, and Pubmed databases. The primary search objective was to identify all papers reporting the results of (1) randomized clinical trials (RCT) of CPAP for the treatment of adults with OSA; and (2) both randomized and non-randomized clinical trials and case series on the surgical treatment of OSA in adults. A PhD-level biostatistician first screened papers, and then those that met study criteria were retrieved and analyzed using standardized forms for each author. The primary outcomes were adherence rates of CPAP. Results: A total of 82 controlled clinical trials for CPAP and 69 controlled and non-controlled surgery trials were identified for analysis. Variation in CPAP use within reported RCT trials were identified, and the majority of patients in the studies would eventually be considered non-adherent to CPAP. Conclusions: When considering the numerous patient-related factors that come into play when CPAP is prescribed, the concept of CPAP as gold-standard therapy for OSA should be reconsidered. In many cases surgery can provide a better overall outcome. This study's results suggest that certain patients with OSA may be managed more effectively with surgery than CPAP, without confounding issues of treatment adherence.
Obstructive Sleep Apnea and Risk of Postoperative Complications after Non-Cardiac Surgery

Rabail Arif Chaudhry,Lori Zarmer,Kelly West,Frances Chung

DOI: https://doi.org/10.3390/jcm13092538

IF: 3.9

2024-04-27

Journal of Clinical Medicine

Abstract:Obstructive sleep apnea (OSA), a common sleep disorder, poses significant challenges in perioperative management due to its complexity and multifactorial nature. With a global prevalence of approximately 22.6%, OSA often remains undiagnosed, and increases the risk of cardiac and respiratory postoperative complications. Preoperative screening has become essential in many institutions to identify patients at increased risk, and experts recommend proceeding with surgery in the absence of severe symptoms, albeit with heightened postoperative monitoring. Anesthetic and sedative agents exacerbate upper airway collapsibility and depress central respiratory activity, complicating intraoperative management, especially with neuromuscular blockade use. Additionally, OSA patients are particularly prone to opioid-induced respiratory depression, given their increased sensitivity to opioids and heightened pain perception. Thus, regional anesthesia and multimodal analgesia are strongly advocated to reduce perioperative complication risks. Postoperative care for OSA patients necessitates vigilant monitoring and tailored management strategies, such as supplemental oxygen and Positive Airway Pressure therapy, to minimize cardiorespiratory complications. Health care institutions are increasingly focusing on enhanced monitoring and resource allocation for patient safety. However, the rising prevalence of OSA, heterogeneity in disease severity, and lack of evidence for the efficacy of costly perioperative measures pose challenges. The development of effective screening and monitoring algorithms, alongside reliable risk predictors, is crucial for identifying OSA patients needing extended postoperative care. This review emphasizes a multidimensional approach in managing OSA patients throughout the perioperative period, aiming to optimize patient outcomes and minimize adverse outcomes.

medicine, general & internal
Perioperative adverse events in adult patients with obstructive sleep apnea undergoing ambulatory surgery: An updated systematic review and meta-analysis

Felicia Ceban,Ellene Yan,Bianca Pivetta,Aparna Saripella,Marina Englesakis,Tong J. Gan,Girish P. Joshi,Frances Chung

DOI: https://doi.org/10.1016/j.jclinane.2024.111464

IF: 9.375

2024-05-10

Journal of Clinical Anesthesia

Abstract:Background The suitability of ambulatory surgery for patients with obstructive sleep apnea (OSA) remains controversial. This systematic review and meta-analysis aimed to evaluate the odds of perioperative adverse events in patients with OSA undergoing ambulatory surgery, compared to patients without OSA. Methods Four electronic databases were searched for studies published between January 1, 2011 and July 11, 2023. The inclusion criteria were: adult patients with diagnosed or high-risk of OSA undergoing ambulatory surgery; perioperative adverse events; control group included; general and/or regional anesthesia; and publication on/after February 1, 2011. We calculated effect sizes as odds ratios using a random effects model, and additional sensitivity analyses were conducted. Results Seventeen studies (375,389 patients) were included. OSA was associated with an increased odds of same-day admission amongst all surgery types (OR 1.94, 95% CI 1.46–2.59, I 2 :79%, P < 0.00001, 11 studies, n = 347,342), as well as when only orthopedic surgery was considered (OR 2.68, 95% CI 2.05–3.48, I 2 :41%, P < 0.00001, 6 studies, n = 132,473). Three studies reported that OSA was strongly associated with prolonged post anesthesia care unit (PACU) length of stay (LOS), while one study reported that the association was not statistically significant. In addition, four studies reported that OSA was associated with postoperative respiratory depression/hypoxia, with one large study on shoulder arthroscopy reporting an almost 5-fold increased odds of pulmonary compromise, 5-fold of myocardial infarction, 3-fold of acute renal failure, and 5-fold of intensive care unit (ICU) admission. Conclusions Ambulatory surgical patients with OSA had almost two-fold higher odds of same-day admission compared to non-OSA patients. Multiple large studies also reported an association of OSA with prolonged PACU LOS, respiratory complications, and/or ICU admission. Clinicians should screen preoperatively for OSA, optimize comorbidities, adhere to clinical algorithm-based management perioperatively, and maintain a high degree of vigilance in the postoperative period.

anesthesiology
Histoplasmin sensitivity in Puerto Rico.

P. Cox

Abstract:
Postoperative Oxygen Therapy in Patients With OSA: A Randomized Controlled Trial

Pu Liao,Jean Wong,Mandeep Singh,David T Wong,Sazzadul Islam,Maged Andrawes,Colin M Shapiro,David P White,Frances Chung

DOI: https://doi.org/10.1016/j.chest.2016.12.005

IF: 9.6

Chest

Abstract:Background: Surgical patients with OSA are at increased risk for perioperative complications. Postoperative supplemental oxygen is commonly used, but it may contribute to respiratory depression in patients with OSA receiving opioids. The objective of the study is to investigate the effect of postoperative supplemental oxygen on arterial oxygen saturation (Sao2), sleep respiratory events, and CO2 level in patients with untreated OSA. Methods: Consented patients with an apnea hypopnea index (AHI) > 5 events per hour on a preoperative polysomnography were randomized (1:1) to oxygen (O2 group) or no oxygen (control group). The O2 group received oxygen at 3 L/min via nasal prongs for three postoperative nights. The primary outcomes were polysomnographic parameters measuring Sao2, sleep respiratory events, and Pco2 measured by transcutaneous CO2 monitor (PtcCO2) on nights 1 through 3. The intention-to-treat and per protocol analysis were completed. Results: There were 123 patients randomized (O2 group: n = 62; control group: n = 61). On night 3, the O2 vs control group had a higher average Sao2 (95.2% ± 3% vs 91.4% ± 4%, respectively; P < .001) and lower oxygen desaturation index (median, 2.3; 25th-75th percentile, 0.2-13.8 vs median, 18.5; 25th-75th percentile, 8.2-45.9 events per hour, respectively; P < .0001). The O2 group had a decreased AHI (median, 8.0; 25th-75th percentile, 2.1-19.9 vs median, 15.6; 25th-75th percentile, 9.5-45.8, respectively; P = .016), hypopnea index (P < .001), and central apnea index (P = .026) and a shortened longest apnea hypopnea duration (P = .002). Although time percentage with PtcCO2 ≥ 55 mm Hg ≥ 10% on postoperative night 1, 2, or 3 was found in 11.4% patients, there was no difference in PtcCO2 between the groups. Conclusions: Postoperative supplemental oxygen was found to improve oxygenation and decrease the AHI without increasing the duration of apnea-hypopnea event or PtcCO2 level. A small number of patients had significant CO2 retention while receiving supplemental oxygen. Trial registry: ClinicalTrials.gov; No.: NCT01552304; URL: www.clinicaltrials.gov.
An update on preoperative assessment and preparation of surgical patients with obstructive sleep apnea

Poorna Madhusudan,Jean Wong,Arun Prasad,Elena Sadeghian,Frances F. Chung,Wong, Jean,Sadeghian, Elena,Chung, Frances F.,Madhusudan, Poorna,Prasad, Arun

DOI: https://doi.org/10.1097/ACO.0000000000000539

2019-10-03

Current Opinion in Anaesthesiology

Abstract:Purpose of review There is a high prevalence of obstructive sleep apnea (OSA) in the surgical population, however, a significant proportion of patients are undiagnosed. The Society of Anesthesia and Sleep Medicine (SASM) has issued recent guidelines for preoperative assessment and preparation of patients with known or suspected OSA. The purpose of this review is to highlight key points in the new guidelines and explore the possibilities of different strategies in optimizing patients with OSA preoperatively. Recent findings Recent knowledge on phenotypes and endotypes has provided a better understanding of the disease and its underlying pathogenesis. Phenotypes refer to the predominant morphological characteristics of an individual whereas endotypes refer to the predominant underlying mechanism of the disease. Phenotypes and endotypes in OSA are heterogenous. Heterogeneity in the pathogenic mechanisms implies that opportunities other than the use of continuous positive airway pressure (CPAP) may exist to optimize or manage OSA patients preoperatively. Summary The prevalence of OSA in surgical patients is high. SASM has made recommendations in their published guidelines for the optimum preoperative preparation of patients with OSA. In the future, research may shift towards finding the underlying mechanism of OSA for targeted therapy.

English Else
Microwave and quantum chemical study of propargyl selenocyanate (HC[triple bond]CCH2SeC[triple bond]N).

H. Møllendal,R. Mokso,J. Guillemin

DOI: https://doi.org/10.1021/jp810810f

Abstract:The microwave spectrum of propargyl selenocyanate (HC[triple bond]CCH(2)SeC[triple bond]N) has been investigated in the 40-80 GHz spectral region at 0 degrees C. The spectra of the ground vibrational state of the (80)Se and (78)Se isotopologues of one conformer were assigned. The first vibrationally excited state of the torsion about the CC-Se bond was also assigned for the (80)Se isotopologue. The identified rotamer has a C-C-Se-C antiperiplanar conformation (C(s) symmetry). The microwave work has been augmented by ab initio calculations at the MP2/6-311++(3df,3pd) level and density functional theory calculations at the B3LYP/6-311G++(3df,3pd) level of theory. Both the ab initio and the B3LYP calculations predict that the identified rotamer is the global minimum and indicate the existence of an additional high-energy anticlinal form. The two theoretical methods predict rather different values for the H(2)C-Se bond length as well as for the C-C-Se-C dihedral angle of the high-energy anticlinal form.
[Condensing osteitis: report of a case].

A. Athanasiou,K. Zarrinnia

1987-08-01

Abstract:
Continuous positive airways pressure for obstructive sleep apnoea

J Wright,J White

DOI: https://doi.org/10.1002/14651858.CD001106

Abstract:Background: Obstructive sleep apnoea (OSA) is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The mainstay of nocturnal treatment is continuous positive airway pressure (CPAP) therapy at home at night to prevent the resulting apnoea, hypoxia and sleep fragmentation which are believed to cause the symptoms of OSA. A number of clinical trials have evaluated the effectiveness of nasal CPAP) as a treatment. Objectives: The objective was to review the effects of CPAP in the treatment of obstructive sleep apnoea in adults. Search strategy: We searched Medline 1966 to 1996, Embase 1974 to 1996, Cinahl 1982 to 1995 and the reference lists of articles. We consulted experts in the field. Selection criteria: Randomised trials comparing nocturnal CPAP with placebo or other treatments in adults with obstructive sleep apnoea and an apnoea/hypopnoea index greater than five per hour. Data collection and analysis: Trial quality was assessed and data were extracted independently by two reviewers. Study authors were contacted for missing information. Main results: Seven trials involving 177 people were included. All the studies had some methodological shortcomings. Six trials were of crossover design. Compared with placebo, CPAP showed significant improvements in several quality of life and depression measures. Patients preferred CPAP to placebo (odds ratio 0.4, 95% confidence interval 0.2 to 0.8). There was no significant effect on blood pressure or measures of sleepiness and sleep quality. Compared with oral appliances, CPAP significantly improved the apnoea/hypopnoea index (weighted mean difference -7.3, 95% confidence interval -10.0 to -4.7) and minimum oxygen saturation during sleep. Patients strongly preferred the oral appliance to CPAP (odds ratio 9.5, 95% confidence interval 4.3 to 21.1). Reviewer's conclusions: CPAP appears to be more effective than placebo in improving some quality of life measures for people with obstructive sleep apnoea. It appears to be more effective than oral appliances in improving respiratory disturbances. People appear to prefer oral appliances over CPAP, but prefer CPAP over placebo.
Continuous positive airways pressure for obstructive sleep apnoea in adults

T L Giles,T J Lasserson,B J Smith,J White,J Wright,C J Cates

DOI: https://doi.org/10.1002/14651858.CD001106.pub2

2006-01-25

Abstract:Background: Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature death, hypertension, ischaemic heart disease, stroke and road traffic accidents. Objectives: The main treatment for sleep apnoea is with the use of continuous positive airways pressure (CPAP), which requires a flow generator and mask. These are used at night to prevent apnoea, hypoxia and sleep disturbance. The objective was to assess the effects of CPAP in the treatment of obstructive sleep apnoea in adults. Search strategy: We searched the Cochrane Airways Group Trials Register and reference lists of articles. We consulted experts in the field. Searches were current to July 2005. Selection criteria: We included randomised trials comparing nocturnal CPAP with an inactive control or oral appliances in adults with obstructive sleep apnoea (an apnoea and hypopnoea index greater than five per hour). Trials had a minimum intervention period of two weeks. Data collection and analysis: Trial quality was assessed and two review authors extracted data independently. Study authors were contacted for missing information. Parallel and crossover group trials were analysed separately. Main results: Thirty-six trials involving 1718 people met the inclusion criteria. Study quality was mixed. Compared with control, CPAP showed significant improvements in objective and subjective sleepiness and several quality of life, cognitive function and depression measures (parallel-group studies: Epworth sleepiness scale (ESS) -3.83 units, 95% CI -4.57 to -3.09; crossover studies: ESS -1.84 units, 95% CI -2.57 to -1.11). Twenty-four hour systolic and diastolic blood pressures were lower with CPAP compared with control (parallel-group trials). Compared with oral appliances, CPAP significantly reduced the apnoea and hypopnoea index (crossover studies: -7.97 events/hr, 95% CI -9.56 to -6.38) and improved sleep efficiency (crossover studies: 2.31%, 95% CI 0.02 to 4.6) and minimum oxygen saturation (4.14%, 95% CI 3.25 to 5.03). Responders to both treatments expressed a strong preference for the oral appliance. However, participants were more likely to withdraw on OA than on CPAP therapy. Authors' conclusions: CPAP is effective in reducing symptoms of sleepiness and improving quality of life measures in people with moderate and severe obstructive sleep apnoea (OSA). It is more effective than oral appliances in reducing respiratory disturbances in these people but subjective outcomes are more equivocal. Certain people tend to prefer oral appliances to CPAP where both are effective. This could be because they offer a more convenient way of controlling OSA. Short-term data indicate that CPAP leads to lower blood pressure than in controls. Long-term data are required for all outcomes in order to determine whether the initial benefits seen in short-term clinical trials persist.
Long Term Cardiovascular Outcomes Between Sleep Surgery and Continuous Positive Airway Pressure

Ann M. Martin,Zachary Elliott,Eric Mastrolonardo,Richard Wu,Joshua Mease,Maurits Boon,Colin Huntley

DOI: https://doi.org/10.1177/00034894241284169

2024-10-24

Annals of Otology Rhinology & Laryngology

Abstract:Annals of Otology, Rhinology &Laryngology, Ahead of Print. Objectives:Individuals with obstructive sleep apnea (OSA) suffer from a multitude of concurrent morbidities including cardiovascular disease (CVD). Limited data exists comparing long term cardiovascular disease (CVD) clinical outcomes for patients treated with surgical intervention versus continuous positive airway pressure (CPAP). The purpose of this study was to compare CVD outcomes at multiple time points comparing those treated with sleep surgery versus CPAP alone.Methods:A research database was used to assess outcomes: death, myocardial infarction, atrial fibrillation, heart failure, essential hypertension, and pulmonary hypertension at 5, 8, and 20 years for patients with OSA treated with surgical interventions (upper airway stimulation [UAS], uvulopalatopharyngoplasty [UPPP], and tonsillectomy) or CPAP alone. Subjects were identified using ICD and CPT codes and analyses were conducted with and without propensity score matching for age, sex, race, BMI, myocardial infarction (MI), essential hypertension, pulmonary hypertension, atrial fibrillation, and heart failure.Results:All surgical interventions demonstrated benefit over CPAP alone at most time points for most surgical interventions. At 8 years, for all sleep surgeries (UAS or UPPP or tonsillectomy) (n = 6627) versus treatment with CPAP alone (n = 6627), matched subjects demonstrated decreased risk (odds ratios) and superior survival (hazard ratios and log ranks tests) for death (OR = 0.49 [0.39, 0.62] P ≤ .0001, HR = 0.29 [0.23, 0.37], χ2 = 109.58 P ≤ .0001), myocardial infarction (OR = 0.67 [0.54, 0.84] P = .0005*, HR = 0.48 [0.38, 0.60], χ2 = 42.40 P ≤ .0001), atrial fibrillation (OR = 0.70 [0.59, 0.83] P ≤ .0001, HR = 0.54 [0.45, 0.64], χ2 = 51.53 P ≤ .0001), heart failure (OR = 0.55 [0.47, 0.64] P ≤ .0001, HR = 0.41 [0.35, 0.47], χ2 = 137.416 P ≤ .0001), essential hypertension (OR = 0.88 [0.82, 0.94] P = .0002, HR = 0.78 [0.74, 0.82], χ2 = 76.38 P ≤ .0001), and pulmonary hypertension (OR = 0.51 [0.40, 0.65] P ≤ .0001, HR = 0.38 [0.29, 0.48], χ2 = 60.67 P ≤ .0001) where P ≤ .00037 indicated statistical significance*.Conclusion:This investigation suggests surgical management of obstructive sleep apnea may contribute to the mitigation of long-term clinical CVD morbidity.

otorhinolaryngology
0585 PAP Therapy Impact on Bariatric Surgery Complications: A 30-Day Pre-Operative Evaluation

Seif Bugazia,Ankita Badhwar,Dania Shakaroun,Arthur Carlin,Timothy Roehrs,Virginia Skiba

DOI: https://doi.org/10.1093/sleep/zsae067.0585

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction The coexistence of obstructive sleep apnea (OSA) and obesity creates an intricate clinical scenario, particularly for individuals pursuing bariatric surgery. OSA increases perioperative risks, including prolonged stay, re-intubation, and cardiovascular events. It is generally recommended that patients with OSA start using Positive Airway Pressure (PAP) therapy before surgery, however studies are mixed on whether use of PAP reduces postoperative or long-term complications, and many include only subjective compliance data. We examined objective pre-operative PAP use among OSA patients undergoing bariatric surgery and its impact in reducing post-operative complications. Methods Our study included data from 140 individuals who underwent bariatric surgery gathered over a 6-month period, with 79 having verified PAP use in the 30-days before surgery. A correlation analysis was conducted comparing 30-day pre-operative PAP use to total operative time, time in the Post-Anesthesia Care Unit (PACU), length of inpatient stay, collective PACU and inpatient time, ED visits within the 30 days post-op. There were no deaths, ICU transfers, respiratory or surgical complications in this sample. Furthermore, PAP use was categorized into tertiles, and an analysis of variances was completed for the following secondary variables: Apnea-Hypopnea Index (AHI), time with oxygen saturation < 88% and < 90%, age, and weight. Mean PAP use in minutes was 376±59 for the highest-use group, 183±61 for intermediate-use group, and 10±16 for lowest-use group. Results Our correlation analysis revealed no significant associations between 30-day pre-operative PAP use and above-mentioned outcomes. Upon PAP use stratification into tertiles, a statistically significant effect became apparent in relation to PACU time (p = 0.008), with oxygen saturation < 88% as a significant covariate. The PACU time in minutes varied across tertiles, with the highest-use group having a PACU time of 169±106, the intermediate-use group with 217± 156s, and the lowest-use group with 202±129. Conclusion Overall, complications rates after bariatric surgery were low. Increased PAP use was significantly associated with shorter stays in the PACU, perhaps related to faster time to recovery from anesthesia due to lower number of desaturations, hence mitigating need for continued nursing monitoring which could potentially lower healthcare associated cost. Support (if any)

neurosciences,clinical neurology
[Redefine the Efficacy of Surgical Treatments for Obstructive Sleep Apnea Hypopnea Syndrome].

Shuifang Xiao,Junbo Zhang

DOI: https://doi.org/10.13201/j.issn.1001-1781.2015.06.004

2015-01-01

Abstract:Various surgical procedures are widely used for treating obstructive sleep apnea hypopnea syndrome (OSAHS) currently. The most prominent advantage of surgery is the excellent long-term adherence, which is just the main limitation for the first-line treatment of continuous positive airway pressure (CPAP). However, nearly all the surgical procedures used now usually could not cure this disease completely. The success rate of the uvulopalatopharyngoplasty, which is the most widely used procedure, can only reach to 40% - 50% in terms of AHI Therefore, there are some opinions that the surgery should not be applied for treating this disease. In fact, the outcomes of surgical treatments should not be only evaluated basing on some of the objective results. In this article, the clinical significance of surgery based on objective and subjective data, and the effects on long-term consequences, the combination of surgery with CPAP, and the possible prospects of surgical treatments for this disease will be discussed. This may help us to redefine the clinical efficacy of surgery for the treatment of OSAHS.
Impact of positive airway pressure therapy on intraocular pressure in obstructive sleep apnea: A systematic review

Mamta Singh,Kunal Deokar,Siddhartha Dutta,Bibhuti P Sinha,Chandan D S Katoch

DOI: https://doi.org/10.1177/11206721241249502

2024-05-02

European Journal of Ophthalmology

Abstract:European Journal of Ophthalmology, Ahead of Print. BackgroundPositive airway pressure (PAP) therapy has been reported to have variable effect on intraocular pressure (IOP) in patients with obstructive sleep apnea (OSA) . The objective of this review is to present a qualitative assessment of available literature on impact of PAP on IOP in patients of OSA.Method: Online databases were searched for relevant articles up to September 2023. It included randomized control trial (RCT), prospective observational study, case control study, cross-sectional study, published abstract having relevant information. The comparator group consisted of OSA patients not receiving the PAP therapy or the pre-PAP IOP. Studies reporting change in IOP immediately after PAP use, at 1 month and at 1 year of PAP use were included. For quality assessment Cochrane Risk of Bias tool version 2 and NIH study quality assessment tool for Before-After (Pre-Post) Studies with No Control Group was used.Result: In this systematic review of ten clinical studies with 191 patients of OSA, use of continuous positive airway pressure (CPAP) therapy led to an immediate increase in IOP but it was not significantly different from non-CPAP users. One month and 1 year of CPAP use led to a significant increase in IOP from the baseline value.ConclusionThe available albeit limited evidence suggests that CPAP use, particularly at higher pressures, is linked to an elevation in IOP. However, high quality evidence from well-designed RCTs is needed to confirm or refute this findings.

ophthalmology
1051 A Novel Sleep Pilot Program to Streamline Care in Patients Undergoing Joint Replacement

Daniella Goldenberg,Edward Rojas,Sirisha Devabhaktuni,Matthew Santer,Valerie Matyus,Jami Pincavitch,Nathan Richmond,Francis Battung,Robert Stansbury,Sunil Sharma

DOI: https://doi.org/10.1093/sleep/zsae067.01051

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction The presence of sleep disordered breathing can have a significant impact on a patient’s perioperative risk. Diagnosis and treatment of obstructive sleep apnea (OSA) with positive air pressure (PAP) may help prevent post-operative complications. In this pilot program we hope to identify high risk patients early to help mitigate these risks. Methods We created a pilot program to help streamline patients undergoing joint replacement. In this program we identified high risk OSA patients, set them up with evaluation with our sleep medicine team and had them undergo standard of care sleep apnea testing. Once testing was completed patients received treatment if indicated. Results A total of 49 patients were evaluated 53% (26) of patients completed evaluation with the sleep medicine team. 8 out of the 49 patients completed their perioperative sleep apnea testing and had undergone their surgery. 9 out of the 49 patients did not complete their perioperative testing and had undergone surgery. Of the 9 that did not complete testing 4(44%) had readmission/visit to the emergency department (ED) post-surgery. 1 out of 8 (12%) who did complete testing had a readmission/visit to the ED. The average AHI of patients who completed testing was 14.67. Conclusion Early identification and intervention of patients with OSA may lead to less post operative readmissions/ED visits in patients undergoing joint replacement. Of note only 53% of patients completed evaluation with the sleep medicine team. This further identifies the importance of discussing with patients the risks that certain comorbidities may have when undergoing procedures. Although the sample size was small due to this being a pilot study, there was a 44% readmission/ED visit rate in patients who did not undergo testing or treatment for OSA. Further studies are needed to see if we can identify which patients with high suspicion for OSA are at greater risk for developing post operative complications to help streamline care and reduce hospital costs. Support (if any)

neurosciences,clinical neurology
Long-term effects on clinical event, mental health, and related outcomes of CPAP for obstructive sleep apnea: a systematic review

Ethan M Balk,Gaelen P Adam,Wangnan Cao,Monika Reddy Bhuma,Carolyn D'Ambrosio,Thomas A Trikalinos,Ethan M. Balk,Gaelen P. Adam,Carolyn D’Ambrosio,Thomas A. Trikalinos

DOI: https://doi.org/10.5664/jcsm.11030

2024-02-01

Journal of Clinical Sleep Medicine

Abstract:STUDY OBJECTIVES: Systematic review of long-term health outcomes of continuous positive airway pressure (CPAP) use in adults with obstructive sleep apnea.METHODS: We updated prior systematic reviews with searches in multiple databases through January 3, 2023. We included randomized controlled trials (RCTs) and adjusted nonrandomized comparative studies (NRCSs) that reported specified long-term (mostly >1 year) health outcomes. We assessed risk of bias, conducted meta-analyses, and evaluated strength of evidence.RESULTS: We found 38 eligible studies (16 trials, 28 observational). All conclusions were of low strength of evidence given study and data limitations. RCTs found no evidence of effect of CPAP on mortality (summary effect size [ES] 0.89; 95% CI 0.66, 1.21); inclusion of adjusted NRCSs yields an association with reduced risk of death (ES 0.57; 95% CI 0.44, 0.73). RCTs found no evidence of effects of CPAP for cardiovascular death (ES 0.99; 95% CI 0.64, 1.53), stroke (ES 0.99; 95% CI 0.73, 1.35), myocardial infarction (ES 1.05; 95% CI 0.78, 1.41), incident atrial fibrillation (ES 0.89; 95% CI 0.48, 1.63), and composite cardiovascular outcomes (all statistically nonsignificant). RCTs found no evidence of effects for incident diabetes (ES 1.02; 95% CI 0.69, 1.51) and accidents (all nonsignificant), and no clinically significant effects on depressive symptoms, anxiety symptoms, or cognitive function.CONCLUSIONS: Whether CPAP use for obstructive sleep apnea affects long-term health outcomes remains largely unanswered. RCTs and NRCSs are inconsistent regarding the effect of CPAP on mortality. Current studies are underpowered, with relatively short duration follow-up and methodological limitations.

clinical neurology
Best perioperative practices in the management of obstructive sleep apnea patients undergoing ambulatory surgery

Ameya Pappu,Mandeep Singh

DOI: https://doi.org/10.1097/aco.0000000000001441

2024-10-19

Current Opinion in Anaesthesiology

Abstract:This review is timely due to the increasing prevalence of obstructive sleep apnea (OSA) among patients undergoing ambulatory surgery, necessitating updated perioperative management strategies to improve outcomes and reduce complications.

anesthesiology

Vasculogenic mimicry in vitro in tumour cells derived from metastatic malignant pleural effusions.

Positive Airway Pressure in Surgical Patients with Sleep Apnea: What is the Supporting Evidence?

Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery

Reconsidering first-line treatment for obstructive sleep apnea: a systematic review of the literature

Obstructive Sleep Apnea and Risk of Postoperative Complications after Non-Cardiac Surgery

Perioperative adverse events in adult patients with obstructive sleep apnea undergoing ambulatory surgery: An updated systematic review and meta-analysis

Histoplasmin sensitivity in Puerto Rico.

Postoperative Oxygen Therapy in Patients With OSA: A Randomized Controlled Trial

An update on preoperative assessment and preparation of surgical patients with obstructive sleep apnea

Microwave and quantum chemical study of propargyl selenocyanate (HC[triple bond]CCH2SeC[triple bond]N).

[Condensing osteitis: report of a case].

Continuous positive airways pressure for obstructive sleep apnoea

Continuous positive airways pressure for obstructive sleep apnoea in adults

Long Term Cardiovascular Outcomes Between Sleep Surgery and Continuous Positive Airway Pressure

0585 PAP Therapy Impact on Bariatric Surgery Complications: A 30-Day Pre-Operative Evaluation

[Redefine the Efficacy of Surgical Treatments for Obstructive Sleep Apnea Hypopnea Syndrome].

Impact of positive airway pressure therapy on intraocular pressure in obstructive sleep apnea: A systematic review

1051 A Novel Sleep Pilot Program to Streamline Care in Patients Undergoing Joint Replacement

Long-term effects on clinical event, mental health, and related outcomes of CPAP for obstructive sleep apnea: a systematic review

Best perioperative practices in the management of obstructive sleep apnea patients undergoing ambulatory surgery